Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
AOD9604 and Energy Balance Research In obese ob/ob and lean C57BL/6J mice treated for 14 days via mini-osmotic pumps, AOD9604 significantly reduced body weight gain in obese mice, associated with increased in vivo fat oxidation and increased plasma glycerol levels as an index of enhanced lipolysis without the hyperglycaemia or reduced insulin secretion associated with intact hGH treatment
Growth hormone receptor modulation and its implications for obesity therapy
Take three measurements and average them
Routine bloodwork through a primary care provider can identify a deficiency early
US$ 26.42
US$ 22.77
US$ 26.36
US$ 22.95
US$ 25.36
